Millennium

Decibel Therapeutics raises $82M as Laurence Reid looks to steer gene therapy pivot
Endpoints
Mon, 11/9/20 - 10:57 am
Decibel Therapeutics
Alnylam
Millennium
gene therapy
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Watson challenges patent on cancer drug Velcade
Yahoo/AP
Fri, 12/28/12 - 11:29 am
Watson Pharmaceuticals
Velcade
Millennium
Multiple Myeloma
Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma
Equities.com
Mon, 12/24/12 - 10:53 am
Infinity Pharmaceuticals
P13K-Delta
Millennium
Millennium starts Phase 3 trial for amyloidosis
Mass High Tech, MA
Sat, 10/20/12 - 11:46 am
MLN9708
Millennium
amyloidosis
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe
Enhanced Online News
Sat, 07/21/12 - 12:11 pm
Adcetris
Takeda
Millennium
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Pharmabiz
Sat, 06/30/12 - 04:35 pm
MLN9708
Multiple Myeloma
Millennium
Millennium withdraws cancer drug application
Bizjournals.com
Thu, 10/6/11 - 11:56 am
Millennium
Velcade
follicular lymphoma
JNJ
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Yahoo/BusinessWire
Sat, 09/24/11 - 12:48 pm
Seattle Genetics
Millennium
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
Sat, 06/11/11 - 10:58 am
systemic anaplastic large cell lymphoma
Seattle Genetics
Millennium
Adcetris
Millennium and Seattle Genetics Announce Brentuximab Vedotin (SGN-35) Presentations at 16th Congress of the European Hematology Association
Yahoo/BusinessWire
Sat, 05/28/11 - 11:56 am
Millennium
Seattle Genetics
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Sunesis posts 1Q profit on Millennium payment
Yahoo/AP
Thu, 05/12/11 - 11:46 am
Sunesis
earnings
Millennium
Millennium signs licensing pact with Sunesis Pharma
Pharmaceutical Business Review
Wed, 04/6/11 - 08:40 am
Sunesis
Millennium
pan-Raf
kinase inhibitors
Millennium expands cancer pact with red-hot Seattle Genetics
Fierce Biotech
Tue, 03/15/11 - 12:27 pm
Millennium
Seattle Genetics
antibody-drug conjugate
Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/5/10 - 11:47 am
Seattle Genetics
Millennium
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Takeda
District Court Denies Teva's Motion to Stay Integrelin Case
Seeking Alpha
Wed, 04/21/10 - 10:27 am
Teva Pharmaceuticals
Integrilin
ANDAs
Millennium
Millennium strikes $365M deal for Seattle Genetics' cancer antibody
Fierce Biotech
Tue, 12/15/09 - 09:25 am
Seattle Genetics
Millennium
antibodies
cancer
Millennium rebuked by FDA over labeling
Bizjournals.com
Thu, 06/25/09 - 05:04 pm
Millennium
FDA
Velcade
Takeda's Millennium Looking For Deals To Bolster Pipeline
WSJ Online
Mon, 06/1/09 - 11:11 pm
Takeda
Millennium
pipelines
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium
Yahoo
Mon, 04/6/09 - 09:24 am
Seattle Genetics
Millennium
partnerships
Takeda